Patents by Inventor Saija Ahonen

Saija Ahonen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of GYS1 expression
    Patent number: 11713462
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of GYS1 in an individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a glycogen storage disease or disorder in an individual in need.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: August 1, 2023
    Assignees: Ionis Pharmaceuticals, Inc., The Hospital for Sick Children
    Inventors: Tamar R. Grossman, Susan M. Freier, Berge Minassian, Saija Ahonen
  • MODULATION OF GYS1 EXPRESSION
    Publication number: 20220112502
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of GYS1 in an individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a glycogen storage disease or disorder in an individual in need.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Tamar R. Grossman, Susan M. Freier, Berge Minassian, Saija Ahonen
  • Modulation of GYS1 expression
    Patent number: 11236339
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of GYS1 in an individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a glycogen storage disease or disorder in an individual in need.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: February 1, 2022
    Assignees: Ionis Pharmaceuticals, Inc., The Hospital for Sick Children
    Inventors: Tamar R. Grossman, Susan M. Freier, Berge Minassian, Saija Ahonen
  • MODULATION OF GYS1 EXPRESSION
    Publication number: 20190194666
    Abstract: Provided herein are methods, compounds, and compositions for reducing expression of GYS1 in an individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a glycogen storage disease or disorder in an individual in need.
    Type: Application
    Filed: June 19, 2017
    Publication date: June 27, 2019
    Applicants: Ionis Pharmaceuticals, Inc., The Hospital for Sick Chlidren
    Inventors: Tamar R. Grossman, Susan M. Freier, Berge Minassian, Saija Ahonen